{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:41:06Z","timestamp":1793400066483,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1904207"],"award-info":[{"award-number":["U1904207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91849115"],"award-info":[{"award-number":["91849115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771290"],"award-info":[{"award-number":["81771290"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974211"],"award-info":[{"award-number":["81974211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901300"],"award-info":[{"award-number":["81901300"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["2020-PT310-01"],"award-info":[{"award-number":["2020-PT310-01"]}]},{"name":"National Key Research and Development Program of China","award":["2017YFA0105003"],"award-info":[{"award-number":["2017YFA0105003"]}]},{"name":"Scientific and Technological Project of Henan Province","award":["SBGJ202003020"],"award-info":[{"award-number":["SBGJ202003020"]}]},{"name":"the Innovative and Scientific and Technological Talents Training Project of Henan Province","award":["YXKC2021062"],"award-info":[{"award-number":["YXKC2021062"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00415-022-11258-w","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:10:12Z","timestamp":1659089412000},"page":"6386-6394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"269","author":[{"given":"Yun","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhe","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2689-9897","authenticated-orcid":false,"given":"Yuming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"issue":"4","key":"11258_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","volume":"141","author":"AS Harms","year":"2021","unstructured":"Harms AS, Ferreira SA, Romero-Ramos M (2021) Periphery and brain, innate and adaptive immunity in Parkinson\u2019s disease. Acta Neuropathol 141(4):527\u2013545","journal-title":"Acta Neuropathol"},{"issue":"9","key":"11258_CR2","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ng.642","volume":"42","author":"TH Hamza","year":"2010","unstructured":"Hamza TH et al (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson\u2019s disease. Nat Genet 42(9):781\u2013785","journal-title":"Nat Genet"},{"issue":"5","key":"11258_CR3","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.ajhg.2013.10.009","volume":"93","author":"WT Wissemann","year":"2013","unstructured":"Wissemann WT et al (2013) Association of Parkinson disease with structural and regulatory variants in the HLA region. Am J Hum Genet 93(5):984\u2013993","journal-title":"Am J Hum Genet"},{"issue":"9","key":"11258_CR4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls MA et al (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat Genet 46(9):989\u2013993","journal-title":"Nat Genet"},{"issue":"6","key":"11258_CR5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/mds.27659","volume":"34","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat C et al (2019) Parkinson\u2019s disease age at onset genome-wide association study: Defining heritability, genetic loci, and \u03b1-synuclein mechanisms. Mov Disord 34(6):866\u2013875","journal-title":"Mov Disord"},{"issue":"2","key":"11258_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.20338","volume":"57","author":"Y Ouchi","year":"2005","unstructured":"Ouchi Y et al (2005) Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease. Ann Neurol 57(2):168\u2013175","journal-title":"Ann Neurol"},{"issue":"2","key":"11258_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A et al (2006) In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol Dis 21(2):404\u2013412","journal-title":"Neurobiol Dis"},{"issue":"8","key":"11258_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12149-016-1099-2","volume":"30","author":"T Terada","year":"2016","unstructured":"Terada T et al (2016) Extrastriatal spreading of microglial activation in Parkinson\u2019s disease: a positron emission tomography study. Ann Nucl Med 30(8):579\u2013587","journal-title":"Ann Nucl Med"},{"issue":"11","key":"11258_CR9","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"XY Qin","year":"2016","unstructured":"Qin XY et al (2016) Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol 73(11):1316\u20131324","journal-title":"JAMA Neurol"},{"issue":"1","key":"11258_CR10","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12974-018-1206-5","volume":"15","author":"CH Williams-Gray","year":"2018","unstructured":"Williams-Gray CH et al (2018) Abnormalities of age-related T cell senescence in Parkinson\u2019s disease. J Neuroinflammation 15(1):166","journal-title":"J Neuroinflammation"},{"issue":"3","key":"11258_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0753-3322(99)80079-1","volume":"53","author":"H Bessler","year":"1999","unstructured":"Bessler H et al (1999) IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson\u2019s disease. Biomed Pharmacother 53(3):141\u2013145","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"11258_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1034\/j.1600-0404.2000.101003159.x","volume":"101","author":"Y Hasegawa","year":"2000","unstructured":"Hasegawa Y et al (2000) Impaired cytokine production by peripheral blood mononuclear cells and monocytes\/macrophages in Parkinson\u2019s disease. Acta Neurol Scand 101(3):159\u2013164","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"11258_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-014-1345-4","volume":"128","author":"V Grozdanov","year":"2014","unstructured":"Grozdanov V et al (2014) Inflammatory dysregulation of blood monocytes in Parkinson\u2019s disease patients. Acta Neuropathol 128(5):651\u2013663","journal-title":"Acta Neuropathol"},{"issue":"11","key":"11258_CR14","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/mds.27815","volume":"34","author":"SK Nissen","year":"2019","unstructured":"Nissen SK et al (2019) Alterations in blood monocyte functions in Parkinson\u2019s disease. Mov Disord 34(11):1711\u20131721","journal-title":"Mov Disord"},{"issue":"16","key":"11258_CR15","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","volume":"116","author":"L Ziegler-Heitbrock","year":"2010","unstructured":"Ziegler-Heitbrock L et al (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116(16):e74-80","journal-title":"Blood"},{"issue":"3","key":"11258_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/mds.25300","volume":"28","author":"N Funk","year":"2013","unstructured":"Funk N et al (2013) Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson\u2019s disease. Mov Disord 28(3):392\u2013395","journal-title":"Mov Disord"},{"issue":"5","key":"11258_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","volume":"27","author":"K Wakabayashi","year":"2007","unstructured":"Wakabayashi K et al (2007) The Lewy body in Parkinson\u2019s disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology 27(5):494\u2013506","journal-title":"Neuropathology"},{"issue":"5","key":"11258_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2006.11.013","volume":"29","author":"A Klegeris","year":"2008","unstructured":"Klegeris A et al (2008) Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia. Neurobiol Aging 29(5):739\u2013752","journal-title":"Neurobiol Aging"},{"issue":"6","key":"11258_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W et al (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J 19(6):533\u2013542","journal-title":"FASEB J"},{"issue":"12","key":"11258_CR20","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1096\/fj.06-6183com","volume":"20","author":"A Klegeris","year":"2006","unstructured":"Klegeris A et al (2006) Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells. FASEB J 20(12):2000\u20132008","journal-title":"FASEB J"},{"issue":"13","key":"11258_CR21","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","volume":"17","author":"OM El-Agnaf","year":"2003","unstructured":"El-Agnaf OM et al (2003) Alpha-synuclein implicated in Parkinson\u2019s disease is present in extracellular biological fluids, including human plasma. FASEB J 17(13):1945\u20131947","journal-title":"FASEB J"},{"issue":"3","key":"11258_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1096\/fj.03-1449com","volume":"20","author":"OM El-Agnaf","year":"2006","unstructured":"El-Agnaf OM et al (2006) Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease. FASEB J 20(3):419\u2013425","journal-title":"FASEB J"},{"issue":"1","key":"11258_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo G et al (2013) Triggering of inflammasome by aggregated \u03b1-synuclein, an inflammatory response in synucleinopathies. PLoS ONE 8(1):e55375","journal-title":"PLoS ONE"},{"key":"11258_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah4066","author":"R Gordon","year":"2018","unstructured":"Gordon R et al (2018) Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aah4066","journal-title":"Sci Transl Med"},{"issue":"12","key":"11258_CR25","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601","journal-title":"Mov Disord"},{"key":"11258_CR26","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3389\/fimmu.2020.01070","volume":"11","author":"S Cormican","year":"2020","unstructured":"Cormican S, Griffin MD (2020) Human monocyte subset distinctions and function: insights from gene expression analysis. Front Immunol 11:1070","journal-title":"Front Immunol"},{"key":"11258_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fncel.2018.00247","volume":"12","author":"SA Ferreira","year":"2018","unstructured":"Ferreira SA, Romero-Ramos M (2018) Microglia response during Parkinson\u2019s disease: alpha-synuclein intervention. Front Cell Neurosci 12:247","journal-title":"Front Cell Neurosci"},{"issue":"15","key":"11258_CR28","first-page":"4084","volume":"54","author":"LM Weiner","year":"1994","unstructured":"Weiner LM et al (1994) Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects. Cancer Res 54(15):4084\u20134090","journal-title":"Cancer Res"},{"issue":"5","key":"11258_CR29","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1182\/blood-2010-12-326355","volume":"118","author":"KL Wong","year":"2011","unstructured":"Wong KL et al (2011) Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118(5):e16-31","journal-title":"Blood"},{"key":"11258_CR30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.bbi.2020.01.018","volume":"87","author":"RS Wijeyekoon","year":"2020","unstructured":"Wijeyekoon RS et al (2020) Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson\u2019s disease. Brain Behav Immun 87:473\u2013488","journal-title":"Brain Behav Immun"},{"issue":"3","key":"11258_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ni1309","volume":"7","author":"NV Serbina","year":"2006","unstructured":"Serbina NV, Pamer EG (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7(3):311\u2013317","journal-title":"Nat Immunol"},{"issue":"7","key":"11258_CR32","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1523\/JNEUROSCI.3567-08.2009","volume":"29","author":"C D'Mello","year":"2009","unstructured":"D\u2019Mello C, Le T, Swain MG (2009) Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J Neurosci 29(7):2089\u20132102","journal-title":"J Neurosci"},{"key":"11258_CR33","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3389\/fneur.2018.01081","volume":"9","author":"JB Schr\u00f6der","year":"2018","unstructured":"Schr\u00f6der JB et al (2018) Immune cell activation in the cerebrospinal fluid of patients with Parkinson\u2019s disease. Front Neurol 9:1081","journal-title":"Front Neurol"},{"issue":"1","key":"11258_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00365513.2011.626868","volume":"72","author":"HJ M\u00f8ller","year":"2012","unstructured":"M\u00f8ller HJ (2012) Soluble CD163. Scand J Clin Lab Invest 72(1):1\u201313","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"11258_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/JLB.5HI0119-018R","volume":"106","author":"I Grondman","year":"2019","unstructured":"Grondman I et al (2019) Frontline science: endotoxin-induced immunotolerance is associated with loss of monocyte metabolic plasticity and reduction of oxidative burst. J Leukoc Biol 106(1):11\u201325","journal-title":"J Leukoc Biol"},{"issue":"1","key":"11258_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","volume":"23","author":"M Reale","year":"2009","unstructured":"Reale M et al (2009) Peripheral cytokines profile in Parkinson\u2019s disease. Brain Behav Immun 23(1):55\u201363","journal-title":"Brain Behav Immun"},{"key":"11258_CR37","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3389\/fneur.2018.00870","volume":"9","author":"RS Wijeyekoon","year":"2018","unstructured":"Wijeyekoon RS et al (2018) Monocyte function in Parkinson\u2019s disease and the impact of autologous serum on phagocytosis. Front Neurol 9:870","journal-title":"Front Neurol"},{"issue":"4","key":"11258_CR38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neures.2010.12.020","volume":"69","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L et al (2011) Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line. Neurosci Res 69(4):337\u2013342","journal-title":"Neurosci Res"},{"key":"11258_CR39","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3389\/fneur.2018.00946","volume":"9","author":"AJ White","year":"2018","unstructured":"White AJ et al (2018) The peripheral inflammatory response to alpha-synuclein and endotoxin in Parkinson\u2019s disease. Front Neurol 9:946","journal-title":"Front Neurol"},{"issue":"1","key":"11258_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41392-021-00650-z","volume":"6","author":"Y Li","year":"2021","unstructured":"Li Y et al (2021) Inflammasomes as therapeutic targets in human diseases. Signal Transduct Target Ther 6(1):247","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"11258_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071634","volume":"8","author":"SJ Gardai","year":"2013","unstructured":"Gardai SJ et al (2013) Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson\u2019s disease. PLoS ONE 8(8):e71634","journal-title":"PLoS ONE"},{"issue":"1","key":"11258_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/jir.2019.0085","volume":"40","author":"KK Gupta","year":"2020","unstructured":"Gupta KK, Khan MA, Singh SK (2020) Constitutive inflammatory cytokine storm: a major threat to human health. J Interferon Cytokine Res 40(1):19\u201323","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"11258_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12974-016-0588-5","volume":"13","author":"K Brockmann","year":"2016","unstructured":"Brockmann K et al (2016) Inflammatory profile in LRRK2-associated prodromal and clinical PD. J Neuroinflammation 13(1):122","journal-title":"J Neuroinflammation"},{"issue":"8","key":"11258_CR44","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/gps.5124","volume":"34","author":"E King","year":"2019","unstructured":"King E et al (2019) Inflammation in mild cognitive impairment due to Parkinson\u2019s disease, Lewy body disease, and Alzheimer\u2019s disease. Int J Geriatr Psychiatry 34(8):1244\u20131250","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"11258_CR45","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/mds.28424","volume":"36","author":"SK Nissen","year":"2021","unstructured":"Nissen SK et al (2021) Soluble CD163 changes indicate monocyte association with cognitive deficits in Parkinson\u2019s disease. Mov Disord 36(4):963\u2013976","journal-title":"Mov Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11258-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11258-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11258-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T12:04:39Z","timestamp":1667131479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11258-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["11258"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11258-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"assertion":[{"value":"6 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C Shi reports research support from the National Natural Science Foundation of China (Grants 81771290 and 81974211); C Mao reports research support from the National Natural Science Foundation of China (Grant 81901300), and the Scientific and Technological Project of Henan Province (Grant SBGJ202003020),\u00a0and the Innovative and Scientific and Technological Talents Training Project of Henan Province (Grant YXKC2021062). Y Xu reports research support from the National Natural Science Foundation of China (Grant U1904207 and 91849115), the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (Grant 2020-PT310-01), and the National Key Research and Development Program of China (Grant 2017YFA0105003); Y Su, T Wang, C Liu, J Yang, S Zhang, L Fan, H Zheng, X Li, H Luo, S Zhang, Z Hu, Y Fan, X Hao, C Zhang, and B Song have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the institutional ethics committee (2013-52).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants included in the study, in accordance with the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}